Balchem Corporation is a specialty ingredients and solutions company that develops, manufactures, and distributes performance products for nutrition, food, pharmaceuticals, animal health, medical device sterilization, plant nutrition, and industrial applications. The company operates through three main segments: Human Nutrition and Health, which supplies ingredients and delivery systems used in food, beverage, and supplement formulations; Animal Nutrition and Health, which provides nutritional ingredients and technologies for livestock and companion animal markets; and Specialty Products, which includes packaged performance gases and chemical products used in healthcare and other industrial settings. Balchem Corporation serves customers worldwide by combining formulation expertise, ingredient functionality, and application-specific technologies. Founded in 1967 and headquartered in Montvale, New Jersey, Balchem Corporation plays a broad role in specialty ingredient supply chains across health, nutrition, and industrial markets.
Website5 Paragon Drive
Montvale, NJ, 07645
United States
Balchem has delivered a 35.5% return over the past 3 years, which naturally prompts the question of whether the current share price is well supported by the cash the business can generate. With the stock recently closing at US$167.84, the gap between the recent share-price path and the underlying cash flows is what matters most for investors now. The 35.5% return over 3 years highlights the importance of assessing whether Balchem's current market value aligns with the cash it is expected to...
MONTVALE, N.J., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in the 9th Annual Wells Fargo Consumer Conference on September 23, 2026. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer and Allison Baurichter, Senior Director Investor Relations will participate in the conference. About Balchem Corpor
28th consecutive quarter of EBITDA growth driven by volume and pricing gains.
Detailed price information for Balchem Corp (BCPC-Q) from The Globe and Mail including charting and trades.
Investors talking about BCPC also mention
What share of all stock conversation is about BCPC?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% new | 0% new | 0% 0 | 0% 0 |
Of the messages about BCPC that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | — | — | — | 100% 0 | ||
| Bearish | — | — | — | 0% 0 |
Of the messages about BCPC that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Announcements | — | — | — | 39.57% | ||
| Earnings | — | — | — | 10.43% | ||
| Analysts | — | — | — | 6.96% | ||
| Controversies | — | — | — | 0% | ||
| Macro | — | — | — | 43.04% | ||
| Technical Analysis | — | — | — | 0% |
Of the messages about BCPC, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | 0% | 0% | 0% | 33.72% | ||
| Newcomers | 100% | 100% | 100% | 66.28% |